Voyager Therapeutics
VYGR
136 hedge funds and large institutions have $123M invested in Voyager Therapeutics in 2026 Q2 according to their latest regulatory filings, with 19 funds opening new positions, 58 increasing their positions, 34 reducing their positions, and 16 closing their positions.
3,244% more call options, than puts
Call options by funds: $1.81M | Put options by funds: $54K
71% more repeat investments, than reductions
Existing positions increased: 58 | Existing positions reduced: 34
19% more first-time investments, than exits
New positions opened: 19 | Existing positions closed: 16
1.77% more ownership
Funds ownership: 56.24% → 58.01% (+1.8%)
1% more funds holding
Funds holding: 135 → 136 (+1)
5% less capital invested
Capital invested by funds: $129M → $123M (-$6.67M)
Top Buyers
| Rank | Fund | Capital Flow |
|---|---|---|
| 1 |
Millennium Management
New York
|
+$3.85M |
| 2 |
Citadel Advisors
Miami,
Florida
|
+$1.59M |
| 3 |
Two Sigma Investments
New York
|
+$1.26M |
| 4 |
Geode Capital Management
Boston,
Massachusetts
|
+$1.06M |
| 5 |
PAM
Panagora Asset Management
Boston,
Massachusetts
|
+$876K |
Top Sellers
| Rank | Fund | Capital Flow |
|---|---|---|
| 1 |
EAM
Erste Asset Management
Vienna,
Austria
|
-$1.73M |
| 2 |
BlackRock
New York
|
-$1.5M |
| 3 |
VPC
Vestal Point Capital
New York
|
-$1.43M |
| 4 |
WP
Woodline Partners
San Francisco,
California
|
-$749K |
| 5 |
Hudson Bay Capital Management
Stamford,
Connecticut
|
-$603K |
VYGR Hedge Fund Activity: Q2 2026 in Review
136 of the 8,287 institutional investors tracked by Wall St. Rank reported a position in Voyager Therapeutics (VYGR) for Q2 2026, worth a combined $123M — down 5.2% from $129M a quarter earlier.
Buyers outnumbered sellers: 19 funds opened new VYGR positions and 16 closed out — a net gain of 3 holders — while 58 added to existing stakes and 34 trimmed.
The largest buyer was Millennium Management, adding an estimated $3.85M. The largest seller was Erste Asset Management, cutting an estimated $1.73M.
- 136 institutional investors held Voyager Therapeutics (VYGR) as of Q2 2026, up from 135 in Q1 2026.
- Funds reported $123M of Voyager Therapeutics stock for Q2 2026, down 5.2% quarter-over-quarter.
- 19 funds opened new Voyager Therapeutics positions in Q2 2026 and 16 closed out, a net change of +3 holders.
- The largest Voyager Therapeutics buyer in Q2 2026 was Millennium Management, an estimated $3.85M added.
- The largest Voyager Therapeutics seller in Q2 2026 was Erste Asset Management, an estimated $1.73M sold.
Based on aggregated 13F filings for Q2 2026.